| abstract |
Derivative of arylalkylpyridazinone of the general formula I wherein R 1 is n. and R.sup.2.n. H or A, R.sup.3.n. and R.sup.4.n. on top of OH, -OR.sup.10.n., -SR.sup.10.n., -SOR.sup.10.n., - SO.sub.2.nRsup.10.n. , Hal, methylenedioxy, -NO.sub.2, -NH.sub.2, -NHR.sup.10.n. or NR.sup.10.n.R.sup.11.n, R.sup.5.n. phenyl pop pad with one or two substituents R.sup.6. and / or R.sup.7.n. Q C.sub.1-6.n.alkylene or errors, R.sup.6.n. and R.sup.7.n. -NH.sub.2.n., -NR.sup.8.nRsup.9.n.-, -NHR.sup.10.n., NR.sup.10.nRsup.11.n , -NO, 2, Hal, -CN, -OA, -COOH, or -COOA, R 8, c. and R.sup.9.n. no H, C.sub.1-8.n.acyl poppad substituted single map of F and / or Cl, -COOA, -SO-A, -SO.sub.2-A, - CONH.sub.2, -CONHA, -CONA.sub.2, -CO-COOH, -CO-COOA, -CO-CONH.sub.2, -CO-CONHA or - CO-CONA.sub.2.n. And C.sub.1-6n alkyl substituted with one and the other of F and / or Cl, R.sup.10. and R.sup.11.n. H, F, Cl, Br or I, H, F, Cl, Br. , and its physiologically acceptable salts exhibit the phosphodiester z IV brakes and are suitable for treating processes such as allergies, asthma and autoimmune diseases. |